Periodic safety reporting schedule
Active Substances | Trade Name | MAH | Year of registration in Saudi Arabia | International Birth Date (IBD) | PSUR Submission Frequency | Data Lock Point (DLP) | Submission Date |
---|---|---|---|---|---|---|---|
Iloprost | Ventavis | BAYER PHARMA AG | 3 years | ||||
Dapagliflozin | FORXIGA | AstraZeneca | annual | ||||
Panitumumab | Vectibix | AMGEN | Annual | ||||
Eltrombopag olamine | Eltrombopag Olamine | GLAXOSMITHKLINE (GSK) | annual | ||||
Fluxetine | Prozac | Eli Lilly | 3 years | ||||
Regorafenib | Stivarga | BAYER PHARMA AG | annual | ||||
Estradiol hemihydrate | Vagifem 25 mcg | NOVO NORDISK | 3 years | ||||
Suxamethonium | MIDARINE | GLAXOSMITHKLINE (GSK) | 3 years | ||||
Estradiol hemihydrate | Vagifem 25 mcg | NOVO NORDISK | 3 years | ||||
Riociguat | Adempas | BAYER PHARMA AG | annual |